Abstract
Carvedilol (Coreg) is a nonselective β-adrenergic blocking agent with vasodilating activity. It is used for the treatment of congestive heart failure and hypertension. During the bulk synthesis of carvedilol, we have observed six impurities: Imp-I, Imp-II, Imp-III, Imp-IV, Imp-V, and Imp-VI. The present work describes the synthesis and characterization of these impurities.
ACKNOWLEDGMENTS
The authors are grateful to colleagues in the Analytical Research and Development department and the management of Srini Pharmaceuticals Ltd. for providing the necessary support.